BRAF mutations have been identified in various cancers with high frequency in melanomas (50–60%) and thyroid cancers (30–90%); and BRAF mutations are mostly V600E substitution 4; 8; 9; 10; 11; 12; 13; 14; 15. This evidence concerns the gene BRAF and thyroid gland carcinoma.